<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>447</number>
    <updateDate>2024-07-24T15:24:03Z</updateDate>
    <updateDateIncludingText>2024-07-24T15:24:03Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-01-24</introducedDate>
    <congress>118</congress>
    <cdata/>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2023-01-24T17:00:35Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2023-01-24T17:00:30Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2023-01-24</actionDate>
        <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-01-24</actionDate>
        <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-01-24</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-01-24</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>G000582</bioguideId>
        <fullName>Rescom. González-Colón, Jenniffer [R-PR-At Large]</fullName>
        <firstName>Jenniffer</firstName>
        <lastName>Gonzalez-Colon</lastName>
        <party>R</party>
        <state>PR</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S000168</bioguideId>
        <fullName>Rep. Salazar, Maria Elvira [R-FL-27]</fullName>
        <firstName>Maria</firstName>
        <lastName>Salazar</lastName>
        <party>R</party>
        <state>FL</state>
        <middleName>Elvira</middleName>
        <district>27</district>
        <sponsorshipDate>2023-01-24</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000593</bioguideId>
        <fullName>Rep. Gimenez, Carlos A. [R-FL-28]</fullName>
        <firstName>Carlos</firstName>
        <lastName>Gimenez</lastName>
        <party>R</party>
        <state>FL</state>
        <middleName>A.</middleName>
        <district>28</district>
        <sponsorshipDate>2023-09-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M000317</bioguideId>
        <fullName>Rep. Malliotakis, Nicole [R-NY-11]</fullName>
        <firstName>Nicole</firstName>
        <lastName>Malliotakis</lastName>
        <party>R</party>
        <state>NY</state>
        <district>11</district>
        <sponsorshipDate>2023-10-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Taxation</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Aging</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Business expenses</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Business investment and capital</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Cardiovascular and respiratory health</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Community life and organization</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Economic development</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Emergency medical services and trauma care</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Government studies and investigations</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Housing and community development funding</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Immunology and vaccination</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Income tax credits</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Income tax deductions</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Industrial facilities</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Infectious and parasitic diseases</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Manufacturing</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Medical research</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Medical tests and diagnostic methods</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Minority and disadvantaged businesses</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Minority health</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Poverty and welfare assistance</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Public-private cooperation</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Research administration and funding</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Research and development</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Strategic materials and reserves</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Unemployment</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Veterans' medical care</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
        <item>
          <name>Wages and earnings</name>
          <updateDate>2023-03-20T13:30:46Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Taxation</name>
        <updateDate>2023-02-08T00:45:35Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-01-24</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2023-02-08T20:18:32Z</updateDate>
        <text><![CDATA[ <p><b>Medical Manufacturing, Economic Development, and Sustainability Act of 2023 or the MMEDS Act of 2023</b></p> <p>This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical manufacturers. The bill increases the credit rate for minority businesses.</p>]]></text>
      </summary>
    </summaries>
    <title>MMEDS Act of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>MMEDS Act of 2023</title>
        <updateDate>2024-07-24T15:24:03Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>MMEDS Act of 2023</title>
        <updateDate>2024-05-24T13:42:56Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Medical Manufacturing, Economic Development, and Sustainability Act of 2023</title>
        <updateDate>2024-05-24T13:42:56Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To rescue domestic medical manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.</title>
        <updateDate>2024-03-18T20:13:22Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2023-01-24T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr447ih/xml/BILLS-118hr447ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-01-24</actionDate>
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
